Qualigen Therapeutics (QLGN) Stock: Partners with BitGo for $30 Million Crypto Treasury Strategy

**Qualigen Therapeutics (QLGN) Surges 5% Following $30 Million Cryptocurrency Treasury Partnership with BitGo**

Qualigen Therapeutics (NASDAQ: QLGN) stock jumped 5% after announcing a strategic partnership with leading cryptocurrency custody provider BitGo for a $30 million digital asset treasury initiative. The biotechnology company's bold move into cryptocurrency diversification involves investing across 10 different digital currencies, marking a significant shift toward blockchain-based treasury management.

This cryptocurrency adoption strategy positions Qualigen among a growing number of public companies embracing Bitcoin and digital assets as hedge investments. BitGo, renowned for institutional-grade cryptocurrency custody solutions, will provide secure storage and management services for Qualigen's diversified crypto portfolio.

The partnership reflects increasing mainstream adoption of cryptocurrency treasury strategies, with companies seeking alternatives to traditional cash holdings amid market volatility. Qualigen's $30 million commitment demonstrates confidence in long-term cryptocurrency market growth and blockchain technology's potential.

Investors responded positively to the cryptocurrency integration news, driving QLGN stock higher in pre-market trading. This strategic crypto treasury diversification could provide additional revenue streams while exposing shareholders to potential digital asset appreciation across multiple cryptocurrency holdings.